Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis.

BACKGROUND The prognostic significance of histology in ileal pouch-anal anastomosis (IPAA) remains unclear. The aim of this study was to evaluate if histologic variables are predictive of IPAA clinical outcomes and healthcare utilization. METHODS This was a retrospective cohort study of patients with IPAA undergoing surveillance pouchoscopy at a tertiary care institution. Pouch body biopsies were reviewed by gastrointestinal pathologists, who were blinded to clinical outcomes, for histologic features of acute or chronic inflammation. Charts were reviewed for clinical outcomes including development of acute pouchitis, chronic pouchitis, biologic or small molecule initiation, hospitalizations, and surgery. Predictors of outcomes were analyzed using univariable and multivariable logistic and Cox regression. RESULTS A total of 167 patients undergoing surveillance pouchoscopy were included. Polymorphonuclear leukocytes (odds ratio [OR], 1.67), ulceration and erosion (OR, 2.44), chronic inflammation (OR, 1.97), and crypt distortion (OR, 1.89) were associated with future biologic or small molecule initiation for chronic pouchitis. Loss of goblet cells was associated with development of chronic pouchitis (OR, 4.65). Pyloric gland metaplasia was associated with hospitalizations (OR, 5.24). No histologic variables were predictive of development of acute pouchitis or surgery. In an exploratory subgroup analysis of new IPAA (<1 year), loss of goblet cells was associated with acute pouchitis (OR, 14.86) and chronic pouchitis (OR, 12.56). Pyloric gland metaplasia was again associated with hospitalizations (OR, 13.99). CONCLUSIONS Histologic findings may be predictive of IPAA outcomes. Pathologists should incorporate key histologic variables into pouchoscopy pathology reports. Clinicians may need to more closely monitor IPAA patients with significant histologic findings.

[1]  Samir A. Shah,et al.  Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. , 2021, The lancet. Gastroenterology & hepatology.

[2]  Samir A. Shah,et al.  Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. , 2021, The lancet. Gastroenterology & hepatology.

[3]  Ahmed M. Almradi,et al.  Disease Activity Indices for Pouchitis: A Systematic Review. , 2021, Inflammatory bowel diseases.

[4]  M. Silverberg,et al.  An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials , 2021, Alimentary pharmacology & therapeutics.

[5]  M. Mikuła,et al.  Pyloric gland metaplasia: Potential histologic predictor of severe pouch disease including Crohn's disease of the pouch in ulcerative colitis. , 2021, Pathology, research and practice.

[6]  Ahmed M. Almradi,et al.  An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials. , 2021, Gastroenterology.

[7]  M. Regueiro,et al.  Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  M. Dubinsky,et al.  Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis , 2019, Alimentary pharmacology & therapeutics.

[9]  A. Rogers,et al.  Meta-analysis of Histological Margin Positivity in the Prediction of Recurrence After Crohn's Resection. , 2019, Diseases of the colon and rectum.

[10]  Siddharth Singh,et al.  Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2019, The American journal of gastroenterology.

[11]  L. Laine,et al.  Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis , 2016, The American Journal of Gastroenterology.

[12]  J. Salleron,et al.  A practical guide to assess the Nancy histological index for UC , 2016, Gut.

[13]  M. Silverberg,et al.  Intraepithelial lymphocytosis is a frequent finding in biopsies from ileal pouch-anal anastomoses. , 2016, Human pathology.

[14]  B. Warren,et al.  Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up , 2015, Gut.

[15]  Sjoerd Post,et al.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system , 2014, Immunological reviews.

[16]  M. Silverberg,et al.  Ileal pouch symptoms do not correlate with inflammation of the pouch. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  D. Rubin,et al.  Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  T. Heeren,et al.  Is Pyloric Gland Metaplasia in Ileal Pouch Biopsies a Marker for Crohn’s Disease? , 2013, Digestive Diseases and Sciences.

[19]  J. Goldblum,et al.  Increased Crypt Apoptosis Is a Feature of Autoimmune-Associated Chronic Antibiotic Refractory Pouchitis , 2012, Diseases of the colon and rectum.

[20]  V. Fazio,et al.  Perioperative Factors During Ileal Pouch-Anal Anastomosis Predict Pouchitis , 2011, Diseases of the colon and rectum.

[21]  A. Ristimäki,et al.  Risk of cancer in patients with chronic pouchitis after restorative proctocolectomy for ulcerative colitis , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[22]  J. Goldblum,et al.  Pyloric gland metaplasia and pouchitis in patients with ileal pouch‐anal anastomoses , 2010, Alimentary pharmacology & therapeutics.

[23]  J. Connor,et al.  Modified Pouchitis Disease Activity Index , 2003, Diseases of the colon and rectum.

[24]  F. Autschbach,et al.  Diagnosing Pouchitis , 2002, Diseases of the colon and rectum.

[25]  K. Tschöp,et al.  Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. , 1997, Gastroenterology.

[26]  K. Batts,et al.  Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. , 1994, Mayo Clinic proceedings.

[27]  F. Reinholt,et al.  Different types of mucosal adaptation in the ileal reservoir after restorative proctocolectomy , 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.